Juniper Pharma Balance Sheet - Quarterly (NASDAQ:JNP)

Add to My Stocks
$11.5 $0 (0%) JNP stock closing price Aug 14, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Juniper Pharma, and helps in stock analysis. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Juniper Pharma stock analysis, and provides insights into the firm's financial performance. Quarterly results are typically accompanied with the company releasing financial statements. Apart from analyzing Juniper Pharma revenue Juniper Pharma operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Juniper Pharma balance sheet for 2018 Q2 shows cash on hand of $20.83M. The company has a debt to equity ratio of -.

View and download Juniper Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities----------
Raw Materials1.38M1.82M1.92M2.02M-1.34M---1.06M
Work In Progress4.06M3.7M3.29M3.09M4.05M2.87M3.8M3.49M2.23M1.71M
Finished Goods--1.1M--1.47M----
Notes Receivable----------
Other Current Assets3.23M2.67M3.46M2.15M1.81M1.49M1.53M1.34M3.29M2.82M
Total Current Assets
Property Plant & Equipment26.49M25.06M23.71M23.06M22.11M20.62M19.7M18.65M17.98M18.39M
Accumulated Depreciation9.42M9.18M8.48M7.94M7.3M6.78M6.33M6.08M5.8M5.63M
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable----------
Accounts Payable7.17M5.07M4.03M4.6M3.46M2.7M3.89M4.77M3.83M3.82M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses7.4M3.91M5.61M5.73M5.13M4.3M5.27M4.45M4.03M3.16M
Income Taxes Payable----------
Other Current Liabilities--6.14M7.44M7.19M6.44M5.62M5.81M1.28M1.28M
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt2.91M3.23M3.25M3.36M3.39M3.35M2.2M2.37M2.5M2.75M
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus294.58M294.06M292.1M291.85M291.46M290.97M290.63M290.24M289.92M289.57M
Retained Earnings-233.8M-232.28M-238.96M-240.12M-238.71M-238.8M-237.36M-246.97M-241.79M-240.04M
Treasury Stock8.66M8.66M8.6M8.6M8.6M8.6M8.6M8.6M8.6M8.6M
Other Liabilities-3.75M-2.21M-3.15M-3.33M-3.97M-4.8M-5.02M-4.02M-3.36M-1.82M
Shareholders Equity48.49M51.02M41.51M39.91M40.29M39.44M40.32M31.32M36.84M39.77M
Total Liabilities & Shareholders Equity67.77M64.53M61.22M61.75M60.02M56.8M57.57M49M48.99M51.58M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Apart from balance sheet items, an investor would do well to keep track of the Juniper Pharma stock price by looking at Juniper Pharma historical stock prices. One can compare PE with industry average by looking at the Juniper Pharma PE ratio chart. The common balance sheet items are:

  • Assets: JNP total assets, which was at $67.77M for 2018 Q2 is a balance sheet item representing value of what Juniper Pharma owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. JNP stock had total liabilities of $19.28M for the quarter 2018 Q2.

Juniper Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover